Two episodes of Ph+ acute leukemia with divergent Ig/TCR rearrangements in two patients with persistent <i>BCR::ABL1</i> positivity: a 17-year follow-up

Authors

Inge M. van der Sluis (ORCID: https://orcid.org/0000-0002-5822-7668)
Edwin Sonneveld (ORCID: https://orcid.org/0000-0002-1869-0957)
Michel Zwaan
Maaike Luesink
Elisabeth Salzer (ORCID: https://orcid.org/0000-0002-8118-4934)
P. J. Hoogerbrugge
Pieters Rob
Alba Rubio-San-Simón

Institutions

Leiden University Medical Center (NL)
Hospital Infantil Universitario Niño Jesús (ES)
Princess Máxima Center (NL)
Erasmus MC - Sophia Children’s Hospital (NL)

Publication Details

Journal: Haematologica
Published: 2025-12-24
DOI: https://doi.org/10.3324/haematol.2025.288671
Primary Topic: Chronic Myeloid Leukemia Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Pfizer
Sanofi
Gilead Sciences
Incyte
Syndax Pharmaceuticals
EUSA Pharma
Science and Engineering Research Board
Daiichi Sankyo Europe

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Two episodes of Ph+ acute leukemia with divergent Ig/TCR rearrangements in two patients with persistent BCR::ABL1 positivity: a 17-year follow-up

Inge M. van der Sluis, Edwin Sonneveld, Michel Zwaan, Maaike Luesink et al.

Dec 24, 2025

Haematologica

Chronic Myeloid Leukemia Treatments

article

Two episodes of Ph+ acute leukemia with divergent Ig/TCR rearrangements in two patients with persistent BCR::ABL1 positivity: a 17-year follow-up

Inge M. van der Sluis, Edwin Sonneveld, Michel Zwaan, Maaike Luesink, Elisabeth Salzer, P. J. Hoogerbrugge, Pieters Rob, Alba Rubio-San-Simón

December 24, 2025article en

Abstract

No abstract available for this paper.

Haematologica

Leiden University Medical Center (NL), Hospital Infantil Universitario Niño Jesús (ES), Princess Máxima Center (NL), Erasmus MC - Sophia Children’s Hospital (NL)

Pfizer, Sanofi, Gilead Sciences, Incyte, Syndax Pharmaceuticals, EUSA Pharma, Science and Engineering Research Board, Daiichi Sankyo Europe

Openalex Percentile: Top 25%

Chronic Myeloid Leukemia Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.